Evidence that the aberrant α1→2fucosyltransferase found in colorectal carcinoma may be encoded by Fuc-TIII (Le) gene

Anticancer Research

Volumn 17, Issue 6 D, 1997, Pages 4563-4569

  Nakamura, Jun Ichi ^a   Mogi, Akira ^a   Asao, Takayuki ^a   Nagamachi, Yukio ^a   Yazawa, Shin ^a,b  

^a GUNMA UNIVERSITY   (Japan)

^b JAPAN IMMUNORESEARCH LABORATORIES   (Japan)

Author keywords

1 2fucosylated antigens; Aberrant 1 2fucosyltransferase; Colorectal carcinoma; Fuc TIII gene

Indexed keywords

FUCOSYLTRANSFERASE;

ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PURIFICATION; ENZYME SPECIFICITY; FUCOSYLATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANIMALS; CARBOHYDRATE SEQUENCE; COLORECTAL NEOPLASMS; COS CELLS; DNA PRIMERS; FUCOSYLTRANSFERASES; HUMANS; KINETICS; MOLECULAR SEQUENCE DATA; OLIGOSACCHARIDES; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECOMBINANT PROTEINS; SUBSTRATE SPECIFICITY; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0031409712     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Hakomori S: Aberrant glycosylation in cancer cell membranes as focused on glycolipid: overview and perspectives. Cancer Res 45: 2405-2414, 1985.
2. x blood group antigens in human gastric carcinoma and in normal gastric tissue. Cancer Res 49: 745-752, 1989.
3. Ørntoft TF, Greenwell P, Clausen H and Watkins WM: Regulation of the oncodevelopmental expression of type 1 chain ABH and Lewis blood group antigens in human colon by α-2-L-fucosylation. Gut 32: 287-293, 1991.
4. b-glycolipids in human tissue. Biochim Biophys Acta 202: 225-228, 1970.
5. Y) defined by monoclonal antibody AH6 in different location of colonic epithelia, various histological type of colonie polyps, and adenocarcinomas. Cancer Res 46: 2639-2644, 1986.
6. y blood group related antigens in human malignant, premalignant, and non-malignant colorectal tissues. Cancer Res 46: 5985-5992, 1986.
7. Yazawa S, Akamatsu S, Tachikawa T, Naitoh H, Nakamura J, Asao T, Nagamachi Y, Nakajima T, Shin S and Chia D: Development and characterization of a novel anti-fucosylated antigen monoclonal antibody YB-2 and its usefulness in the immuno-histochemical diagnosis of colorectal cancer. Jpn J Cancer Res 84: 641-648, 1993.
8. b and Y antigens in colorectal tumors. Jpn J Cancer Res 84: 989-995, 1993.
9. Yazawa S, Nishihara S, Iwasaki H, Asao T, Nagamachi Y, Matta KL and Narimatsu H: Genetic and enzymatic evidence for Lewis enzyme expression in Lewis-negative cancer patients. Cancer Res 55: 1473-1478, 1995.
10. Schenkel-Brunner H: Human Blood Groups: Chemical and Biochemical Basis of Antigen Specificity. Springer-Verlag, New York, 1995, pp.146-192.
11. b and Y glycolipids in the gastric carcinoma cell line KATO III as analyzed by a novel assay. Biochem Biophys Res Commun 151: 100-108, 1988.
12. Chandrasekaran EV, Jain RK, Rhodes JM, Sruka CA, Larsen RD and Matta KL: Expression of blood group Lewis b determinant from Lewis a : Association of the novel α(1,2)-L-fucosylating activity with the Lewis type α(1,3/4)-L-fucosyltransferase. Biochemistry 34: 4748-4756, 1995.
13. Weiger MM, Klohs WD, Podolsky DK and Wilson JR: The Glycoconjugates, Vol IV (ed.) Horowitz MI, Academic Press, New York, 1982, pp.301-333.
14. Yazawa S, Madiyalakan R, Izawa H, Asao T, Furukawa K and Matta KL: Cancer-associated elevation of α(1→3)-L-fucosyltransferase activity in human cancer. Cancer 62: 516-520, 1988.
15. Yazawa S, Asao T, Izawa H, Miyamoto Y and Matta KL: The presence of CA19-9 in serum and saliva from Lewis blood-group negative cancer patients. Jpn J Cancer Res 79: 538-543, 1988.
16. Yazawa S, Asao T, Nagamachi Y and Matta KL : Elevated activities of serum α(1→ 3)-L-fucosyltransferase in human cancer. J Tumor Marker Oncol 4: 355-362, 1989.
17. Tachikawa T, Yazawa S, Asao T, Shin S and Yanaihara N: Novel method for quantifying α(1→3)-L-fucosyltransferase activity in serum. Clin Chem 37: 2081-2086, 1991.
18. Macher BA, Holmes EH, Swiedler SJ, Stulto CLM and Srnka CA: Human α1-3 fucosyltransferases. Glycobiology 1: 577-584, 1991.
19. Kubishiro K, Tsukazaki K, Sakuma Y, Akiba Y, Sakayori M, Aoki R, Yazawa S and Nozawa S :Expression of human uterine endometrial cancer-specific fucosylated carbohydrate chains: Aberrant α1→4fucosyltransferases in uterine endometrial cancer-derived cell lines with type I carbohydrate chain. Int J Oncol 6: 93-97, 1995.
20. Hada T, Fukui K, Ohno M, Akamatsu S, Yazawa S, Enomoto K, Yamaguchi K, Matsuda Y, Amano Y, Yamanaka N, Okamoto E and Higashi K : Increased plasma α(1→3)-L-fucosyltransferase activities in patients with hepatocellular carcinoma. Glycoconjugate J 12: 627-631, 1995.
21. Kubishiro K, Tsukazaki K, Sakuma Y Sakayori M. Yazawa S and Nozawa S : Enzymatic basis for the accumulation of Lewis(b) antigen in uterine endometrial cancer. Jpn. J Cancer Res 86: 361-367, 1995.
22. Lowe JB, Stoolman LM, Nair RP, Larsen RD, Berhend TL and Marks RM: ELAM-1-dependent cell adhesion to vascular endothelium determined by a transfected human fucosyltransferase cDNA. Cell 63: 475-484, 1990.
23. Kukowska-Latallo JF, Larsen RD, Nair RP and Lowe JB : A cloned human cDNA determines expression of a mouse stage-specific embryonic antigen and the Lewis blood group α(1,3/1,4) fucosyltransferase. Gene Dev 4: 1288-1303, 1990.
24. Larsen RD, Ernst LK, Nair RP, Lowe JB: Molecular cloning sequence, and expression of human GDP-L-fucose:ß-D-galactoside 2-α-L-fucosyltransferase cDNA that can form the H group antigen. Proc Natl Acad Sci USA 87: 6674-6678, 1990.
25. Weston BW, Nair RP, Larsen RD and Lowe JB : Isolation of a novel human α(1,3)-fucosyltransferase gene and molecular comparison to the human Lewis blood group α(1,3/1,4)fucosyltransfease gene. J Biol Chem 267: 4152-4160, 1992.
26. Weston BW, Smith PL, Kelly RJ and Lowe JB : Molecular cloning of a fourth member of a human α(1,3)fucosyltransferase gene family. J Biol Chem 267: 24575-24584, 1992.
27. Goelz SE, Hession C, Goff D, Griffiths B, Tizard R, Newman B, ChiRosso G and Lobb R: ELET: A gene that directs the expression of an ELAM-1 ligand, Cell 63: 1349-1356, 1990.
28. Lowe JB, Kukowska-Lattallo JF, Nair RP, Larsen RD, Marks RM, Macher BA, Kelly RJ and Ernst LK : Molecular cloning of a human fucosyltransferase gene that determines expression of the Lewis X and VIM-2 epitopes but not ELAM-1-dependent cell adhesion. J Biol Chem 266: 17467-17477, 1991.
29. Kurmar R, Potvin B, Muller WA and Stanley P : Cloning of a human alpha(1,3)-fucosyltransferase gene that encodes ELFT but does not confer ELAM-1 recognition on Chinese hamster ovary cell transfectants. J Biol Chem 266: 21777-21783, 1991.
30. Koszdin KL and Bowen BR: The cloning and expression of a human α-1,3-fucosyltransferase capable of forming the E-selectin ligand. Biochem Biophys Res Commun 187: 152-157, 1992.
31. Mollicone R, Reguigne A, Fletcher A, Aziz A, Rustam M, Weston BW, Kelly RJ, Lowe BJ and Oriol R : Molecular basis for plasma α(1,3)-fucosyltransferase gene deficiency (FUT6). J Biol Chem 269: 12662-12671, 1994.
32. Sasaki K, Kurata K, Funayama K, Nagata M, Watanabe E, Ohta S, Hanai N and Nishi T: Expression cloning of a novel α1,3-fucosyltransferase that is involved in biosynthesis of the sialyl Lewis x carbohydrate determinants in leukocytes. J Biol Chem 269: 14730-14737, 1994.
33. Natsuka G, Gersten KM, Zenita K, Kannagi R and Lowe JB: Molecular cloning of a cDNA encoding a novel α1,3-L-fucosyltransferase capable of synthesizing the sialyl Lewis x determinant. J Biol Chem 269: 16789-16794, 1994.
34. Rouquier S, Lowe JB, Kelly RJ, Fertitta AL, Lennon GG, Giorgi D: Molecular cloning of a human genomic region containing the H blood group α(1,2)fucosyltransferase gene and two H locus-related DNA restriction fragments. Isolation of a candidate for the human secretor blood group locus. J Biol Chem 270: 4632-4639, 1995.
35. Kelly RJ, Rouquier S, Giorgi D, Lennon GG and Lowe JB : Sequence and expression of a candidate for the human secretor blood group α(1,2)-fucosyltransferase gene (FUT2). J Biol Chem 270: 4640-4649, 1995.
36. Yazawa S and Furukawa K : Immunochemical properties of human plasma α1→2-fucosyltransferase specified by blood group H-gene. J Immunogenet 10: 349-360, 1983.
37. Yazawa S, Furukawa K and Kochibe N: Isolation of fucosyl glycoproteins from human erythrocyte membranes by affinity chromatography using Aleuria aurantia lectin. J Biochem 96: 1737-1742, 1984.
38. Yazawa S, Takeya A, Hosomi A, Nakajima T, Shimoda N, Ohi H, Tachikawa T, Piscorz CF, Jain RK and Malta KL : Use of synthetic H disaccharides as acceptors for detecting activities of UDP-GalNAc: Fucα1→2Galß-R α1→3-Nacetylgalactosaminyl transferase in plasma samples from blood group A subgroups. Clin Chem 38: 2392-2395, 1992.
39. Nishihara S, Narimatsu H, Iwasaki H, Yazawa S, Akamatsu S, Ando T, Seno T, Narimatsu I: Molecular genetic analysis of the human Lewis histo-blood group system. J Biol Chem 269: 29271-29278, 1994.
40. Yazawa S, Oh-kawara H, Nakajima T, Hosomi O, Akamatsu S and Kishi K: Histo-blood group Lewis genotyping from human hairs and blood. Jpn J Human Genet 41: 177-188, 1996.
41. Sun J, Thurin J, Cooper HS, Wang P, Mackiewicz M, Steplewski Z and Blaszyzyk-Thurin M: Elevated expression of H type GDP-L-fucose: β-D-galatoside α-2-L-fucosyltransferase is associated with human colon adenocarcinoma progression. Proc Natl Acad Sci USA 92: 5724-5728, 1995.
42. Nishihara S, Yazawa S, Iwasaki H, Nakazato M, Kudo T, Ando T and Narimatsu H: α(1,3/1,4)fucosyltransferase (FucT-III) gene is inactivated by a single amino acid substitution in Lewis histo-blood type negative individuals. Biochem Biophys Res Commun 196: 624-631, 1993.
43. Mollicone R, Reuguigne I, Kelly RJ, Fletcher A, Watt J, Chatfield, S, Aziz A, Cameron HS, Weston BW, Lowe JB and Oriol R: Molecular basis for Lewis α(1,3/1,4)-fucosyltransferase gene deficiency (FUT3) found in Lewis-negative Indonesian pedigrees. J Biol Chem 269: 20987-20664, 1994.
44. de Vries T, Srnka CA, Palcic MM, Swielder SJ, van den Eijnden DH and Macher BA: Acceptor specificity of different length constructions of human recombinant α1,3/4-fucosyltransferases. J Biol Chem 270: 8712-8722, 1995.
45. Cameron HS, Szczepaniak D and Weston BW: Expression of human chromosome 19p α(1,3)-fucosyltransferase genes in normal tissues. J Biol Chem 270: 20112-20122, 1995.
46. Legault DJ, Kelly RJ, Natsuka Y and Lowe JB: Human α(1,3/1,4)-fucosyltransferases discriminate between different oligosaccharide acceptor susbstrates through a discrete peptide fragment. J Biol Chem 270: 20987-20996, 1995.
47. Xu Z, Vo L and Macher BA: Structure-function analysis of human α1,3-fucosyltransferase. J Biol Chem 277: 8818-8823, 1996.
48. Ørntoft TF, Vestergaard EM, Holmes E, Jalpbsen JS, Grunnet N, Mortensen M, Johnson P, Bross P, Gregersen N, Skorstengaard K, Jensen UB, Bolund L and Wolf H: Influence of Lewis α1-3/4-L-fucosyltransferase (FUT3) gene mutations on enzyme activity, erythrocyte phenotyping, and circulating tumor marker sialyl-Lewis a levels. J Biol Chem 271: 32260-32268, 1996.